LWAYNasdaqDairy ProductsUS GAAP · USD

Lifeway Foods, Inc.

Lifeway Foods, Inc. makes and markets cultured dairy products, with drinkable kefir as its core offering. Founded in 1986, the company built its business by introducing kefir to U.S. consumers and now sells branded and private-label probiotic dairy products across the United States.

Revenue212m USD
+13.7 %y/y
Operating profit (EBIT)16.2m USD
+16.7 %y/y
EBIT margin7.6%
+0.2 ppy/y
Net income13.9m USD
+53.6 %y/y
Free cash flow-16.4m USD
−362.0 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

050100150200250m USD2020: 102 m USD2020: EBIT 4.9 m USD20202021: 119 m USD2021: EBIT 5.9 m USD20212022: 142 m USD2022: EBIT 2.3 m USD20222023: 160 m USD2023: EBIT 17 m USD20232024: 187 m USD2024: EBIT 14 m USD20242025: 212 m USD2025: EBIT 16 m USD202521216
RevenueOperating profit (EBIT)

Business

Share of revenue
Drinkable Kefir60 %

Cultured dairy beverages sold in multiple flavors, sizes, and organic/non-organic formats.

European-style Soft Cheeses10 %

Farmer cheese, white cheese, Sweet Kiss, and related specialty dairy cheeses.

Drinkable Yogurt and ProBugs12 %

Drinkable yogurt and child-focused kefir products marketed under the ProBugs line.

Other Dairy8 %

Fresh Made butter, sour cream, cream, and other dairy byproducts and items.

Private Label and Co-manufactured Products10 %

Products manufactured for retail partners under customer-owned or third-party brands.

Products

Reported · share of revenue
85.4%FY2025100 %
  • Drinkable Kefirotherthan Pro Bugs85.4 %
  • Cheese7.8 %
  • Cream and Other4.1 %
  • Drinkable Yogurt1.1 %
  • Pro Bugs Kefir1.0 %
  • Other Dairy0.6 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

Lifeway sells mainly to U.S. consumers through retail channels, where demand is driven by health, wellness, and probiotic benefits. It also serves private-label customers and food retailers that want differentiated cultured dairy products without building their own manufacturing base. The company’s heritage in ethnic and specialty dairy products still supports a customer base that values traditional Eastern European-style foods.

Retail consumers

Buy branded kefir, yogurt, cheeses, and other dairy products for taste and health benefits.

Grocery and mass retail channels

Stock Lifeway-branded products to meet demand for probiotic and better-for-you dairy.

Private-label partners

Buy manufacturing capacity and product supply for retailer-owned dairy brands.

Families and children

Buy ProBugs and similar products aimed at children and family consumption occasions.

Specialty and ethnic food buyers

Buy farmer cheese, white cheese, and related products tied to Eastern European food traditions.

Strategy

Lifeway is expanding manufacturing capacity and improving packaging efficiency at its Waukesha facility to support rising demand and lower unit costs. It is also strengthening organic milk supply through herd purchases and a third-party dairy arrangement, which should improve input availability for kefir production. Management is balancing growth capital, cost reduction, and facility modernization while maintaining liquidity and covenant compliance.

Waukesha manufacturing expansionMedium term

Adds capacity, improves packaging efficiency, and supports demand growth.

Organic milk supply securityShort term

Improves access to a key input for kefir and reduces supply constraints.

Cost reduction and operational efficiencyMedium term

Supports margins in a business exposed to dairy, labor, and packaging costs.

Geography

Lifeway is primarily a United States-based manufacturer, and management says all domestically produced products are sold to U.S. customers. The company sources most inputs domestically, which reduces direct exposure to foreign supply chains, but it still faces input-cost and tariff-related volatility through dairy and packaging markets. Its manufacturing footprint is centered on U.S. facilities, including the Waukesha, Wisconsin expansion project.

Risks

Lifeway’s business depends on stable dairy input supply, efficient manufacturing, and continued consumer demand for probiotic products. The company is exposed to commodity inflation, tariff and trade uncertainty, and execution risk on its capacity expansion and herd-supply initiatives. Because it sells mainly in the U.S. and relies on a few core product lines, any disruption in supply, demand, or plant performance could affect results quickly.

Sorted by severity
Input cost inflationHigh

Dairy, labor, and packaging costs can rise faster than pricing.

Exposure: Raw materials and manufacturing costs

Capacity expansion executionHigh

The Waukesha project is large and must be completed without disrupting operations.

Exposure: Capital spending and plant operations

Organic milk supply riskHigh

Kefir production depends on reliable milk availability and herd management.

Exposure: Herd agreement and COOP supply arrangement

Supply chain and tariff disruptionMedium

Trade policy changes can increase complexity and commodity volatility.

Exposure: Domestic sourcing and procurement

Demand concentrationMedium

A large share of revenue is tied to kefir and probiotic dairy trends.

Exposure: Product mix and consumer preferences

Accounting

Judgemental items
Herd purchase and dairy agreement accounting

Management is still assessing the proper treatment, which could affect asset, liability, and expense recognition.

Impact: May change balance sheet classification and timing of expense recognition

Capitalized plant expansion costs

Large Waukesha spending must be capitalized correctly and depreciated over useful life.

Impact: Affects PP&E, depreciation expense, and reported operating margin

Inventory and dairy input valuation

Milk and dairy product costs can fluctuate and affect cost of goods sold.

Impact: Impacts gross margin and inventory carrying values

Seasonality and quarterly comparability

Consumer demand and production schedules can vary by quarter in dairy products.

Impact: Affects revenue and margin comparability across periods

Publicly listed companies with a comparable business focus.

Last updated: 28/04/2026

Lifeway Foods, Inc. (LWAY) Revenue, Earnings & Financials 2025 – Clarifo